Life sciences software company Synthace has raised $35 million (€30.6M) in Series C funding to expand the reach of its research and development (R&D) cloud platform, where scientists can record and share their research and insights.
The R&D-focused, no-code software platform enables scientists to share, view and access progress with cures and therapeutics in one place, making it simpler...
Eagle Genomics, a medtech company pioneering the application of network science to microbiome biology, has closed a round of $9 million (€7.6m) scale-up funding. The funding was led by the Environmental Technologies Fund (ETF) and a consortium of investors headed by Granpool Innovative Investments and including Albert-László Barabási, bpd partners and Anatom Holding.
The funding will allow the...
AI has been the buzz word this year across multiple industries and now top government officials are starting to take notice. Yesterday the White House hosted a summit on Artificial Intelligence for American Industry, where it announced a new AI task force. Though the details about the task force are scare, the summit highlighted the use of AI in healthcare.
The summit included over 100 senior...
